Abstract
Rheumatoid arthritis is associated with increased cardiovascular morbidity and mortality due to atherosclerosis. This cannot be explained by an increased presence of traditional risk factors but seems to depend on inflammatory mechanisms. The association of inflammatory pathways with atherosclerosis is complex, and more research is required to optimise preventative measures against cardiovascular complications in inflammatory rheumatic diseases.
Author supplied keywords
- Anti-Inflammatory Agents
- Anti-Inflammatory Agents: therapeutic use
- Anticholesteremic Agents
- Anticholesteremic Agents: therapeutic use
- Arthritis
- Atherosclerosis
- Atherosclerosis: complications
- Atherosclerosis: etiology
- Cardiovascular Diseases
- Cardiovascular Diseases: etiology
- Cardiovascular Diseases: mortality
- Cardiovascular Diseases: prevention & control
- Cytokines
- Cytokines: immunology
- Humans
- Immunosuppressive Agents
- Immunosuppressive Agents: therapeutic use
- Inflammation Mediators
- Inflammation Mediators: immunology
- Rheumatoid
- Rheumatoid: complications
- Rheumatoid: drug therapy
- Rheumatoid: immunology
- Risk Factors
Cite
CITATION STYLE
Troelsen, L. N., & Jacobsen, S. (2006). [Chronic inflammation increases the risk of cardiovascular disease in patients with rheumatoid arthritis]. Ugeskrift for Laeger, 168(39), 3304–8. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17032593
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
